GlassScriptPhysician profile
Harinder S Gill
NPI 1437123049
$12,392.88
in general payments reported to CMS, 2019-2025
36 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,520 · 2020: $2,530 · 2021: $480 · 2022: $417 · 2023: $3,807 · 2024: $260 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,704 · Food and Beverage: $1,642 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,703.66 |
| Food and Beverage | $1,641.75 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,571.70 | 2022-2023 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $1,051.29 | 2019-2022 | |
| Pfizer INC. | $748.07 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $682.24 | 2019-2025 | |
| Amgen INC. | $549.96 | 2019-2020 | |
| Medtronic, INC. | $469.78 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $467.72 | 2019-2024 | Camzyos, Cobenfy |
| Amarin Pharma, INC. | $463.59 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $447.22 | 2019-2020 | |
| Astellas Pharma US INC | $382.53 | 2019-2020 | |
| Daiichi Sankyo INC. | $357.15 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $306.48 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $302.40 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $284.79 | 2019-2020 | |
| United Therapeutics Corporation | $246.22 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $196.96 | 2020 | |
| Boston Scientific Corporation | $193.24 | 2020-2022 | |
| Lundbeck LLC | $187.41 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $168.62 | 2019 | |
| Novo Nordisk INC | $166.60 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $156.56 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.99 | 2019-2021 | |
| Abbott Laboratories | $134.30 | 2019-2025 | Jot Dx, Assurity |
| Esperion Therapeutics, INC. | $131.91 | 2020 | |
| Alexion Pharmaceuticals, INC. | $124.99 | 2019 | |
| Medtronic Vascular, INC. | $121.08 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $99.99 | 2023 | Opsumit, Uptravi |
| Gilead Sciences, INC. | $85.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.27 | 2019 | |
| Bardy Diagnostics, INC. | $20.56 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $20.16 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.29 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $18.23 | 2019 | |
| Infobionic, INC | $12.42 | 2020 | |
| Allergan, INC. | $12.12 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harinder Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.